Sanuwave Health (SNWV)
NASDAQ:SNWV
Want to see SNWV full AI Analyst Report?
Earnings Data
Report Date
May 08, 2026TBA (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
―Last Year’s EPS
-0.66Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a mix of strong financial performance and clear operational momentum against meaningful industry headwinds. Highlights include record Q4 revenue ($13.4M, +30% YoY), strong full-year revenue growth (+35%) and an 89% increase in full-year adjusted EBITDA, a record number of UltraMIST system placements (624 units, +67% YoY) and improved liquidity (cash $12M). Offsetting these positives are significant external challenges driven by CMS reimbursement changes and aggressive audits that have pressured some customers (leading to 168 discontinued systems), a sales-tax restatement that added roughly $1.6M of G&A expense in 2025 (and similar prior-year impacts), inventory write-offs related to sunsetting product lines, elevated operating expenses, and near-term guidance that is modest (Q1 up 3%–10% YoY) while the company executes a channel shift to resellers and works through manufacturing qualification timing. Management communicated a clear strategy to capitalize on the market disruption (select reseller partnerships, reseller wholesale placements, focus on active systems and new 'baby elephant' customers) and expects improvement through 2026, but uncertainty remains in the near term.Company Guidance
Record Quarterly Revenue
Q4 revenue of $13.4 million, a new company quarterly record, up 30% year-over-year (from $10.3M) and in line with guidance ($13M–$14M).
Strong Full-Year Growth
Fiscal 2025 revenue of $44.1 million, up 35% versus 2024, with full-year adjusted EBITDA rising to $13.6 million (an 89% increase versus $7.2M in 2024).
Material Increase in System Sales
Sold 624 UltraMIST systems in 2025 versus 374 in prior year (a 67% increase year-over-year). Q4 system placements were a company record at 255 systems (100 more than prior Q3 record).
Improved Profitability and EBITDA
Q4 adjusted EBITDA of $4.8 million (versus $3.7M prior year) and EBITDA of $8.7M. Q4 net income of $7.7M versus a net loss of $13.3M in Q4 2024 (a $21M swing driven largely by fair-value noncash derivative changes).
Gross Margin Strength and Consumables Demand
Full-year gross margins expanded to ~77% driven by pricing improvements in consumables and lower system cost of revenue; consumables volume rose 24% for the year and system sales rose 67%.
Stronger Liquidity and Current Assets
Total current assets at $24.6 million (vs. $18.4M prior year) and cash & cash equivalents of $12.0 million as of December 31, 2025.
Channel Expansion and New Reseller Strategy
Shift toward stocking resellers/wholesale began in Q3 and continued: 32% of Q4 revenues came through outside resellers/distributors (up from 26% prior quarter). Management expects reseller wholesale placements to accelerate expansion and deliver favorable operating margin fall-through.
Refinancing Reduced Interest Expense and Volatility Expected to Decline
Lower interest expense (helped by senior debt refinanced with JPMorgan at end of Q3 2025) and the majority of warrants now exercised/exchanged/expired, which should limit future noncash swings from derivative liabilities.
SNWV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SNWV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 27, 2026 | $18.85 | $18.61 | -1.27% |
Nov 07, 2025 | $26.41 | $31.08 | +17.68% |
Aug 08, 2025 | $34.32 | $39.76 | +15.85% |
May 09, 2025 | $31.55 | $30.10 | -4.60% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sanuwave Health (SNWV) report earnings?
Sanuwave Health (SNWV) is schdueled to report earning on May 08, 2026, TBA (Confirmed).
What is Sanuwave Health (SNWV) earnings time?
Sanuwave Health (SNWV) earnings time is at May 08, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SNWV EPS forecast?
Currently, no data Available